CCL2 and influenza: It was previously shown that CCL2 recruits CCR2+ inflammatory monocytes to the lung during severe influenza infection and prophylactic use of CCR2 antagonist reduces pulmonary immunopathology, markedly improving the survival of influenza infected mice (Lin et al., 2008, 2011).